The Six Winning Projects of the 12 th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open
"In a context where access to a scientific career is increasingly complex, our Fellowships serve as a tangible tool to support young researchers at a difficult time, promoting merit and innovation", stated Silvia Misiti, Director of IBSA Foundation
Share
The € 32,000 fellowships were awarded to research projects in five scientific areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy aging/regenerative medicine. In particular, this latter category has attracted growing interest over time, recording the highest number of applications this year: 89 projects out of a total of 259.
The winners of the 2024 edition are:
Masami Ando Kuri, Wellcome Sanger Institute, Cellular genetics, Haniffa Lab, Cambridge, UK – Scientific area: dermatology
Enchen Zhou, University of California San Diego, Christopher Glass Laboratory, US – Scientific area: endocrinology
Ilaria Chiaradia, Charles Darwin Department of Biology and Biotechnology, Sapienza University of Rome, Italy – Scientific area: fertility/urology
Prach Techameena, Karolinska Institutet, Neurobiology of Pain & Therapeutics, Saida Hadjab Group, Stockholm, Sweden – Scientific area: pain medicine / orthopaedics / rheumatology
Sergio P é rez Diaz, Karolinska Institutet, Division of Clinical Physiology, Laboratory of Medicine Department, Stockholm, Sweden – Scientific area: healthy aging / regenerative medicine
Vanessa L ó pez Polo, University of California San Francisco, Cardiovascular Research Institute, US – Scientific area: healthy aging/regenerative medicine
'Supporting the talent of young researchers represents for IBSA Foundation a strategic investment, driving scientific progress and fostering a society that is more aware and better equipped to face future challenges. In a context where access to a scientific career is increasingly complex, our Fellowships serve as a tangible tool to support young researchers at a difficult time, promoting merit and innovation ', stated Silvia Misiti, Director of IBSA Foundation for scientific research.
Since its launch in 2012, the IBSA Foundation Fellowships have attracted increasing interest, with 1,645 projects from 60 countries. Over twelve editions, 58 projects have been funded, totalling € 1.6 million.
A particularly noteworthy statistic is the high number of submissions from female researchers: 1,041 out of 1,645 applications, which testifies to their increasingly central role in international scientific research.
At the Milan (Italy) event, IBSA Foundation announced the opening of the 2025 call. Like in 2024, the new edition will award six € 32,000 grants and will welcome projects in five areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy ageing/regenerative medicine. The sixth scholarship will be assigned to the category that receives the highest number of applications.
From this year, the IBSA Foundation Research Equity Prize will also be introduced: worth € 5,000, the prize will be awarded to the best scientific project developed in a laboratory, research institute or university based in a developing country.
Researchers wishing to apply can submit their proposals by January 31, 2026, through the platform.
About IBSA
IBSA (Institut Biochimique SA) is a Swiss pharmaceutical multinational with 20 subsidiaries across Europe, China, and the United States. Its products are available in over 90 countries, and its R&D activities focus on 10 therapeutic areas. In 2025, IBSA will celebrate the 40th anniversary of its acquisition by current President and CEO, Arturo Licenziati, who has transformed the company into a multinational corporation employing over 2,300 personnel worldwide. IBSA's growth and development can be attributed to its ability to innovate by refining well-known molecules, as well as to its commitment to looking to the future responsibly and transparently, thanks to the dedication and dynamism of its people.
About IBSA Foundation for scientific research
Established in 2012 in Lugano by the pharmaceutical company IBSA (Institut Biochimique SA), IBSA Foundation for scientific research is the main promoter of IBSA Group's social responsibility activities.
The Foundation promotes 'Science for all' through accessible information and activities that unite scientific and humanistic culture. Its initiatives include high-level forums featuring internationally renowned scientists, educational events, conferences on art-and-science and health-and-culture and research scholarships in various areas of basic and clinical research.
Expand
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
New research may have found the secret to delaying chronic illness in old age
Imagine two people in their 70s. Both are active, live independently and enjoy life. But over the next 15 years, one of them develops two or three chronic illnesses – heart disease, diabetes, depression – while the other remains relatively healthy. What made the difference? According to our new research, diet may be a key part of the answer. In our new study, our group at the Aging Research Center at the Karolinska Institutet, Sweden, followed more than 2,400 older Swedish adults for 15 years. We found that people who consistently ate a healthy diet developed chronic diseases more slowly, in contrast to those whose diets were considered more inflammatory; that is, diets high in processed meats, refined grains and sugary drinks, which are known to promote low-grade chronic inflammation in the body. This is important because having several health conditions at the same time is one of the biggest problems older people face. It increases the risk of disability, hospitalisation and early death. It also places a huge burden on healthcare systems. But while it has been long known that diet can help prevent individual diseases, our study shows that it may also influence the overall pace of biological ageing. We looked at four well-known dietary patterns. Three of them – the Mind diet (designed to protect brain health), the Alternative Healthy Eating Index (based on foods linked to lower disease risk) and the Mediterranean diet – were associated with slower disease accumulation. The fourth, a diet high in inflammatory foods, was linked to faster accumulation. The strongest associations were seen for cardiovascular and psychiatric conditions. So, people who ate better were less likely to develop diseases including heart failure, stroke, depression or dementia. We did not, however, find a clear link between diet and musculoskeletal diseases such as arthritis or osteoporosis. Some of the benefits of healthy eating were more pronounced in women and in the oldest participants: those aged 78 and above. This suggests that it is never too late to make changes. Even in very old age, diet matters. Why does food have such a strong potential? One reason may be inflammation. As people age, many develop low-grade chronic inflammation – sometimes called 'inflammaging' – which is linked to a wide range of diseases. Diets high in vegetables, fruits, whole grains, and healthy fats tend to reduce inflammation. Diets rich in highly processed foods and sugar do the opposite. Another reason is that healthy diets support the body's resilience. They provide essential nutrients that help maintain immune function, muscle mass and cognitive health. Over time, this can make a big difference in how people age. Our study is one of the longest and most comprehensive of its kind. We used repeated dietary assessments and tracked more than 60 chronic health conditions. We also tested our findings using different analytical methods to make sure they held up. Of course, diet is just one piece of the puzzle. Physical activity, social connections and access to healthcare all play important roles in healthy ageing. But improving diet quality is a relatively simple and accessible way to help older adults live longer, healthier lives. So what should older adults eat? The message is clear: eat plenty of vegetables, fruits, legumes, nuts and whole grains. Choose healthy fats like rapeseed oil and fish. Limit red and processed meats, sugary drinks and solid fats. These are the building blocks of the diets we studied – and they have been associated with slower ageing, better brain health and fewer chronic diseases in this and other research. Ageing is inevitable. But people can shape how it unfolds. Our findings suggest that even small changes in diet can make a meaningful difference in how people experience later life, regardless of their age. Adrián Carballo Casla is a Postdoctoral Researcher in Geriatric Epidemiology at Karolinska Institutet. Amaia Calderón-Larrañaga is an Associate Professor at the Aging Research Center at Karolinska Institutet. David Abbad Gomez is a PhD Candidate in the Department of Epidemiology and Evaluation at Hospital del Mar Research Institute, Barcelona. This article is republished from The Conversation under a Creative Commons license. Read the original article. Solve the daily Crossword
Business Wire
2 days ago
- Business Wire
BerryDunn Showcases Thought Leadership and Expertise at 2025 MESC Conference
PORTLAND, Maine--(BUSINESS WIRE)--BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 25th year to the Medicaid Enterprise Systems Conference (MESC), taking place August 11 – 14 in Milwaukee, WI. The firm is a leading voice in Medicaid and other Health and Human Services (HHS) policy, program excellence, and healthcare data analytics, with decades of hands-on experience supporting states and territories. The MESC brings together territorial, state, federal, and private-sector leaders to discuss and collaborate on Medicaid and other HHS systems and the policies that affect them. Hot topics at MESC 2025 include systems optimization, healthcare IT strategy, and a strong emphasis on modernization, interoperability, and health equity. 'The urgency for the healthcare community to prioritize the well-being of those they serve—while modernizing systems, ensuring compliance, and driving innovation—has never been greater,' says Zachary Rioux, Principal at BerryDunn. 'Our team is deeply committed to helping clients build future-ready solutions that are both strategic and sustainable. We've supported agencies in preparing for and responding to major federal legislation like the One Big Beautiful Bill Act (OBBBA), and we continue to guide clients through the evolving policy landscape.' BerryDunn's involvement with industry associations, governance boards, and conferences enables the consulting team to anticipate and help clients respond to developments like the recent State Health Officials (SHO) letter #25003 and upcoming changes to the Medicaid Information Technology Architecture (MITA). MESC is a powerful gathering of ideas, experience, and purpose—and BerryDunn is proud to be part of a community that's driving meaningful change in healthcare. Several BerryDunn professionals will play a leading role in this year's conference presentations, including: Alexandra Nardo and Robert Morey will speak during a session titled 'Building the Foundation for AI: Puerto Rico's AI Readiness Roadmap.' The session explores the Puerto Rico Medicaid Program's assessment, planning process, and roadmap in support of the agency's AI considerations. Delivering purposeful results through partnership, Amber Davis, a Manager in BerryDunn's Medicaid Practice Group, will moderate a session on 'Advancing Medicaid Innovation through the CMS Leverage & Reuse Initiative.' This session will explore how states and territories are collaborating to drive efficiency, reduce costs, and accelerate innovation in Medicaid technology. Partnering with CMS and the leadership team at the Puerto Rico Medicaid Program (PRMP), Nikki Welch, Manager at BerryDunn, will present 'Leveraging Organizational Change Management (OCM) Maturity Results to Enhance Medicaid Outcomes.' This session highlights PRMP's journey to integrate OCM practices across Medicaid Enterprise Systems (MES) and how the use of BerryDunn's OCM Maturity Assessment framework has provided measurable insights that directly support program success. 'Our team members gain valuable perspective by being actively engaged in Medicaid IT and policy planning at the national and state levels,' says Ed Daranyi, BerryDunn Principal and leader of the firm's Medicaid Practice Group. 'We provide those insights and deep industry knowledge to clients across the country, supporting innovation in client solutions.' As BerryDunn celebrates 25 years at MESC, the firm remains committed to helping agencies navigate complexity with clarity, purpose, and innovation. With deep expertise in policy, technology, and program excellence, BerryDunn continues to lead with insight and impact. About BerryDunn BerryDunn is the brand name under which Berry, Dunn, McNeil & Parker, LLC and BDMP Assurance, LLP, independently owned entities, provide services. Since 1974, BerryDunn has helped businesses, nonprofits, and government agencies throughout the US and its territories solve their greatest challenges. The firm's tax, advisory, and consulting services are provided by Berry, Dunn, McNeil & Parker, LLC, and its attest services are provided by BDMP Assurance, LLP, a licensed CPA firm. BerryDunn is a client-centered, people-first professional services firm with a mission to empower the meaningful growth of our people, clients, and communities. Led by CEO Sarah Belliveau, the firm has been recognized for its efforts in creating a diverse and inclusive workplace culture, and for its focus on learning, development, and well-being. Learn more at
Business Wire
2 days ago
- Business Wire
Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the UBS Precision Medicine Frontiers Summit taking place at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA, August 13-14, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will be available for one-on-one meetings throughout the day on Thursday, August 14, 2025, and Jeff Hawkins will participate in the New Dimensions in Proteomics and Cellular Research panel on the same day from 8:15 – 8:50 AM Pacific Daylight Time. About Quantum-Si Incorporated Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company's platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at or follow us on LinkedIn or X.
